icer glp 1 white paper affordable access to glp-1 obesity medications 2025 Today, we announced that we ⚠️ The math of GLP-1s
Description
- Requires pharmacy practitioners to obtain a licence from the Ministry of Health or local health authorities
Finally, we used initiators of sulfonylureas instead of initiators of SGLT-2 inhibitors as the control
Stopping Safely There may come a time when you need to stop taking your GLP-1 medication, whether due to cost, side effects, or reaching your goals
Your actual pace may be slower if side effects require it
Real-world signals
